激素是一类由生物体内的内分泌腺或细胞分泌的化学物质,它们在体内通过血液循环传递信息,调控多种生理过程。主要分为甾体激素、胺类激素和肽类激素等几大类。
调节内分泌功能的药物主要用于治疗由于体内激素失衡引起的各种疾病,常见的类型有:
替代疗法:
抑制或刺激腺体分泌的药物:
调节胰岛素分泌或作用的药物:
抑制或促进激素生成与释放的药物:
综上所述,调节内分泌功能类药物在治疗多种疾病方面发挥着重要作用。但使用时需遵循医嘱,在专业医生指导下进行,以确保安全性和有效性。
| 中文名称 | 英文名称 | CAS号 | 化学式 |
|---|---|---|---|
| —— | methyl 7-[(1R,2R,3R)-3-hydroxy-2-[(E,3R,5S)-3-hydroxy-5-methylnon-1-enyl]-5-oxocyclopentyl]-6-oxoheptanoate | 70667-26-4 | C23H38O6 |
| —— | Sulprostone | 54348-36-6 | C23H31NO7S |
| —— | tromethamine prostaglandin | 58551-69-2 | C4H11NO3*C21H36O5 |
| —— | N-[1-[[1-[[1-[[1-[[1-[[1-[[1-[2-[(2-azanyl-2-oxidanylidene-ethyl)carbamoyl]pyrrolidin-1-yl]-5-[bis(azanyl)methylideneamino]-1-oxidanylidene-pentan-2-yl]amino]-4-methyl-1-oxidanylidene-pentan-2-yl]amino]-3-naphthalen-2-yl-1-oxidanylidene-propan-2-yl]amino] | 76932-56-4 | C66H83N17O13 |
| —— | Estrumate (TN) | 55028-72-3 | C22H28ClNaO6 |
| —— | (1S,2S,4R,8S,9S,11S,13R)-11-hydroxy-8-(2-hydroxyacetyl)-9,13-dimethyl-6-propyl-5,7-dioxapentacyclo[10.8.0.02,9.04,8.013,18]icosa-14,17-dien-16-one | 51333-22-3 | C25H34O6 |
| —— | 4-[2-(11,17-dihydroxy-10,13-dimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl)-2-oxoethoxy]-4-oxobutanoic acid;hydrate | 83784-20-7 | C25H36O9 |
| —— | Ganirelix Acetate | 129311-55-3 | C84H121ClN18O17 |
| —— | Thyroxine sodium salt | 55-03-8 | C15H11I4NNaO4+ |
| —— | Mylis | 1099-87-2 | C19H28NaO5S+ |
| —— | Sodium levothyroxine pentahydrate | 55-03-8 | C15H21I4NNaO9+ |
| —— | 5-[3,3a,4,5,6,6a-Hexahydro-5-hydroxy-4-(3-hydroxy-4-methyl-1-octen-6-ynyl)pentalen-2(1H)-ylidene]pentanoic acid | 78919-13-8 | C22H32O4 |
| —— | (6Ar,9R)-N-[(2S)-1-hydroxybutan-2-yl]-7-methyl-6,6a,8,9-tetrahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide;but-2-enedioic acid | 57432-61-8 | C24H29N3O6 |
| —— | H-DL-Phe-DL-Cys(1)-DL-Phe-DL-Trp-DL-Lys-DL-xiThr-DL-Cys(1)-Thr-ol.2CH3CO2H | 79517-01-4 | C53H74N10O14S2 |
| —— | buserelin acetate | 68630-75-1 | C2H4O2*C60H86N16O13 |
| —— | 6,17-Dimethyl-6-dehydro-progesteron | 977-79-7 | C23H32O2 |
| —— | noretynodrel | 68-23-5 | C20H26O2 |
| —— | Orgasteron acetate | 6157-87-5 | C21H30O3 |
| —— | 7A-Methyl-19-nortestosterone | 3764-87-2 | C19H28O2 |
| —— | Leuprorelin acetate | 74381-53-6 | C61H88N16O14 |
| —— | (+/-)-Ritodrine hydrochloride | 23239-51-2 | C17H21NO3*ClH |
| —— | S-(fluoromethyl) 6,9-difluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthrene-17-carbothioate | 90566-53-3 | C22H27F3O4S |
| —— | 4-Diethylaminosalicylicacid | 99631-11-5 | C23H28O6 |
| —— | 4-[(2Z,4E)-4-(4-hydroxyphenyl)hexa-2,4-dien-3-yl]phenol | 84-17-3 | C18H18O2 |
| —— | Pharmakon1600-01503921 | 2098-66-0 | C22H27ClO3 |
| —— | Pharmakon1600-00300565 | 17692-51-2 | C25H29N3O2 |
| —— | Pharmakon1600-01503273 | 13609-67-1 | C25H36O6 |
| —— | 16-(3-chlorophenoxy)-17,18,19,20-tetranorprostaglandin F2 alpha | 40665-92-7 | C22H29ClO6 |
| —— | epoprostenol sodium | 61849-14-7 | C20H31O5*Na |
| —— | Octreotide | 83150-76-9 | C49H66N10O10S2 |
| —— | norgestimate | 20799-27-3 | C23H31NO3 |
| —— | Pharmakon1600-01503210 | 5593-20-4 | C28H37FO7 |
| —— | 17β-acetoxy-androst-4-en-3-one | 1045-69-8 | C21H30O3 |
| —— | 8-Isotestosteron-acetat | 1045-69-8 | C21H30O3 |
| —— | [(3E)-13-ethyl-17-ethynyl-3-hydroxyimino-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-yl] acetate | 35189-28-7 | C23H31NO3 |
| —— | Flurogestonacetat | 2529-45-5 | C23H31FO5 |
| —— | [(4R,5R)-4-(hydroxymethyl)-2-oxo-3,3a,4,5,6,6a-hexahydrocyclopenta[b]furan-5-yl] 4-phenylbenzoate | 31752-99-5 | C21H20O5 |
| —— | 17β-undecanoyloxy-androst-4-en-3-one | 5949-44-0 | C30H48O3 |
| —— | 17α-methyl-19-norpregna-4,9-diene-3,20-dione | 10116-22-0 | C21H28O2 |
| —— | Oestriol-cyclopentylaether-(3) | 1169-79-5 | C23H32O3 |
| —— | calcium;(2S)-4-[(3aS,7aR)-1,3,3a,4,5,6,7,7a-octahydroisoindol-2-yl]-2-benzyl-4-oxobutanoate | 145525-41-3 | C38H48CaN2O6 |
| —— | sodium;4-[(1R,2R,3aS,8bS)-2-hydroxy-1-[(3S)-3-hydroxy-4-methyloct-1-en-6-ynyl]-2,3,3a,8b-tetrahydro-1H-cyclopenta[b][1]benzofuran-5-yl]butanoate | 88475-69-8 | C24H29O5*Na |
| —— | (2R,3R,4R,5S,6S)-5-[(2R,3R,4R,5S,6S)-5-[(2R,3R,4S,5S,6S)-3,4-dihydroxy-6-methyl-5-[[(1S,4R,5S,6R)-4,5,6-trihydroxy-3-(hydroxymethyl)cyclohex-2-en-1-yl]amino]oxan-2-yl]oxy-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6-(hydroxymethyl)oxane-2,3,4-triol | 56180-94-0 | C25H43NO18 |
| —— | Dtxcid0028955 | 60325-46-4 | C23H31NO7S |
| —— | Prostaglandin I2; Prostacyclin | 61849-14-7 | C20H31NaO5 |
| —— | Oxytocin injection | 50-56-6 | C43H66N12O12S2 |
| —— | sodium;4-[(2R,3aS,8bS)-2-hydroxy-1-[(E,3S)-3-hydroxy-4-methyloct-1-en-6-ynyl]-2,3,3a,8b-tetrahydro-1H-cyclopenta[b][1]benzofuran-5-yl]butanoate | 88475-69-8 | C24H29NaO5 |
| —— | Pharmakon1600-01500277 | 129-51-1 | C23H27N3O6 |
| —— | Pharmakon1600-01500441 | 6533-00-2 | C21H28O2 |
| —— | Pharmakon1600-01502343 | 5630-53-5 | C21H28O2 |